Canan Hasçiçek
- Pharmaceutical Science top 1%
- Biomaterials top 5%
- Molecular Biology
- Biomedical Engineering
- Materials Chemistry
- Co-authors
- Ceyda Tuba Şengel-TürkNurşin GönülNevin ErkGüneş EsendağlıFiliz Bakar‐AtesSíbel A. ÖzkanDicle GüçA. Lale Doğan
- Topics
- Nanoparticle-Based Drug Delivery (15 papers)Advanced Drug Delivery Systems (15 papers)Drug Solubulity and Delivery Systems (10 papers)
- Journals
- SHILAP Revista de lepidopterologíaEuropean Journal of Pharmaceutics and BiopharmaceuticsAdvances in experimental medicine and biology
In The Last Decade
Canan Hasçiçek
28 papers receiving 540 citations
Peers
Comparison fields: 5 of 98
- Pharmaceutical Science 263
- Biomaterials 217
- Molecular Biology 130
- Biomedical Engineering 110
- Materials Chemistry 39
Countries citing papers authored by Canan Hasçiçek
This map shows the geographic impact of Canan Hasçiçek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canan Hasçiçek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canan Hasçiçek more than expected).
Fields of papers citing papers by Canan Hasçiçek
This network shows the impact of papers produced by Canan Hasçiçek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canan Hasçiçek. The network helps show where Canan Hasçiçek may publish in the future.
Co-authorship network of co-authors of Canan Hasçiçek
This figure shows the co-authorship network connecting the top 25 collaborators of Canan Hasçiçek. A scholar is included among the top collaborators of Canan Hasçiçek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canan Hasçiçek. Canan Hasçiçek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 25 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 8 | |
| 7 | 20 | |
| 8 | 34 | |
| 9 | 22 | |
| 10 | 74 | |
| 11 | 37 | |
| 12 | 12 | |
| 13 | 14 | |
| 14 | 16 | |
| 15 | 12 | |
| 16 | PREPARATION AND EVALUATION OF DIFFERENT GEL FORMULATIONS FOR TRANSDERMAL DELIVERY OF MELOXICAM | 3 |
| 17 | 13 | |
| 18 | 26 | |
| 19 | 5 | |
| 20 | 68 |
About Canan Hasçiçek
Canan Hasçiçek is a scholar working on Pharmaceutical Science, Biomaterials and Analytical Chemistry, having authored 31 papers that have together received 558 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (15 papers), Advanced Drug Delivery Systems (15 papers) and Drug Solubulity and Delivery Systems (10 papers). The work is most often cited by research in Pharmaceutical Science (263 citations), Biomaterials (217 citations) and Molecular Medicine (29 citations). Canan Hasçiçek has collaborated with scholars based in Türkiye and Italy. Frequent co-authors include Ceyda Tuba Şengel-Türk, Nurşin Gönül, Nevin Erk, Güneş Esendağlı, Filiz Bakar‐Ates, Síbel A. Özkan, Dicle Güç, A. Lale Doğan, Mustafa Emre Gedik and Gürcan Günaydın. Their work appears in journals such as SHILAP Revista de lepidopterología, European Journal of Pharmaceutics and Biopharmaceutics and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.